Table 6.
Outcomes in patients with BMI >40, CCI 0-3.
| Outcome & narcotic usage | Liposomal bupivacaine PAI | No PAI | P value |
|---|---|---|---|
| Length of stay (d) | 3 | 3 | 1 |
| Narcotic use 0-24 h (mg) | 156.5 | 99.63 | 0.106 |
| Narcotic use 24-48 h (mg) | 155.39 | 126.75 | 0.38 |
| Narcotic use 48-72 h (mg) | 80 | 83.43 | 0.867 |
| Walking distance POD 1 (ft) | 45.56 | 31.43 | 0.482 |
| Walking distance POD 2 (ft) | 94.38 | 109.38 | 0.738 |
| Walking distance POD 3 (ft) | 96.67 | 156.67 | 0.214 |
POD, postoperative day; PAI, periarticular injection; BMI, body mass index; CCI, Charlson comorbidity index.